Advanced Cell Diagnostics, a developer of cell- and tissue-based diagnostic tests for personalized medicine, has obtained $12m in Series B equity financing round. In the financing round, its existing investor, Morningside Ventures, and ...
Tags: Advanced Cell Diagnostics, cell-and tissue-based diagnostic tests